Detalhe da pesquisa
1.
Discovery of highly neutralizing human antibodies targeting Pseudomonas aeruginosa.
Cell;
186(23): 5098-5113.e19, 2023 11 09.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37918395
2.
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Cell;
182(4): 843-854.e12, 2020 08 20.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32673567
3.
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.
Cell;
180(3): 471-489.e22, 2020 02 06.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32004464
4.
Somatic hypermutation introduces bystander mutations that prepare SARS-CoV-2 antibodies for emerging variants.
Immunity;
56(12): 2803-2815.e6, 2023 Dec 12.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38035879
5.
Single-cell analysis of memory B cells from top neutralizers reveals multiple sites of vulnerability within HCMV Trimer and Pentamer.
Immunity;
56(11): 2602-2620.e10, 2023 Nov 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37967532
6.
Antibody-mediated neutralization of SARS-CoV-2.
Immunity;
55(6): 925-944, 2022 06 14.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35623355
7.
Analysis of antibodies from HCV elite neutralizers identifies genetic determinants of broad neutralization.
Immunity;
55(2): 341-354.e7, 2022 02 08.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34990590
8.
Longitudinal Isolation of Potent Near-Germline SARS-CoV-2-Neutralizing Antibodies from COVID-19 Patients.
Cell;
182(6): 1663-1673, 2020 09 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32946786
9.
HIV-1 integration landscape during latent and active infection.
Cell;
160(3): 420-32, 2015 Jan 29.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25635456
10.
Antibody Teamwork against Ebola Virus Disease.
Immunity;
52(2): 217-219, 2020 02 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32075725
11.
Broadly neutralizing anti-HIV-1 antibodies require Fc effector functions for in vivo activity.
Cell;
158(6): 1243-1253, 2014 Sep 11.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25215485
12.
Structural insights on the role of antibodies in HIV-1 vaccine and therapy.
Cell;
156(4): 633-48, 2014 Feb 13.
Artigo
em Inglês
| MEDLINE
| ID: mdl-24529371
13.
Broadly neutralizing antibodies and viral inducers decrease rebound from HIV-1 latent reservoirs in humanized mice.
Cell;
158(5): 989-999, 2014 Aug 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-25131989
14.
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope.
Immunity;
50(6): 1513-1529.e9, 2019 06 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-31126879
15.
Somatic mutations of the immunoglobulin framework are generally required for broad and potent HIV-1 neutralization.
Cell;
153(1): 126-38, 2013 Mar 28.
Artigo
em Inglês
| MEDLINE
| ID: mdl-23540694
16.
Semen enhances transmitted/founder HIV-1 infection and only marginally reduces antiviral activity of broadly neutralizing antibodies.
J Virol;
98(4): e0119023, 2024 Apr 16.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38501840
17.
Torque Teno Virus load is associated with CDC stage and CD4+ cell count in people living with HIV but unrelated to AIDS-defining events and Human Pegivirus load.
J Infect Dis;
2024 Jan 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38230877
18.
HIV-1 infection of CD4 T cells impairs antigen-specific B cell function.
EMBO J;
39(24): e105594, 2020 12 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-33146906
19.
SARS-CoV-2 targets neurons of 3D human brain organoids.
EMBO J;
39(20): e106230, 2020 10 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32876341
20.
Hybrid immunity to SARS-CoV-2 in patients with chronic lymphocytic leukemia.
Eur J Haematol;
112(5): 788-793, 2024 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38311570